Infrastructure

We’re

Symbiotec is a research-driven, science-based pharmaceutical and biotechnology company with a strong global leadership position in Corticosteroid and Steroidal Hormone Active Pharmaceutical Ingredients (APIs). With over 30 years of industry expertise, we have evolved from a Lab-Scale Steroid manufacturer into a fully integrated global platform

In Fiscal 2025, Symbiotec achieved a Global Volume Market Share of Corticosteroids and Steroidal-Hormone APIs. We are the only Indian and global company with a presence across the Top - Ten categories

Market Leadership

Critical APIs
& Global Dominance

Symbiotec is the only domestic Indian company with a strong presence in major molecules, generating the highest revenue in the steroidal-hormone category.

Hydrocortisone
Testosterone
Methylprednisolone

Our top five flagship products account for an average Global Market Share of 53% by Volume, supported by regulated market DMFs

Innovation Hub

Science-First
R&D Leadership

Our R&D ecosystem is powered by 138 scientists & engineers (including 11 PhDs) across three state-of-the-art research centers

Advanced Chemical Synthesis
Recombinant Proteins (GLP-1 & Insulins)
Precision Fermentation & Biology
Complex Injectable Development

Successfully developed Conjugated Estrogens—A complex API with 82 US FDA-mandated components—securing major global commercialization.

Manufacturing Excellence

Integrated Manufacturing & Advanced Capabilities

Symbiotec operates as a vertically integrated “farm-to-pharmacy” and “microbe-to-pharmacy” platform, enabling superior quality control.

584.67 MT Chemical synthesis capacity across advanced organic chemistry processes

700 KL Fermentation capacity supporting biotechnology and biosynthesis platforms

20 Mn+ Annual complex injectables capacity including vials, bags, and syringes

Core Technology Platforms

Organic Chemistry – Flow Chemistry, Hydrogenation, Photochemistry

Biotechnology – Biosynthesis, Biotransformation, Precision Fermentation

Complex Injectables – Double-Chamber Vials, Syringes, and Drug-Device Combinations

As of June 30, 2025, we are among the few companies globally and the only Indian manufacturer with continuous manufacturing of Progesterone APIs.

Global Footprint

Regulatory Excellence
Across 40+ Countries

Serving over 200 customers globally, supporting leading pharmaceutical innovators with uncompromised quality standards

42 US FDA DMFs

Consistent Global Filings

23 European CEPs

Therapeutic Range

Over 100+ Inspections

Successful Audits

Zero Criticals

Spotless Compliance

Approved by US FDA, EU-GMP, WHO-GMP, and other major regulatory authorities

Our journey

Growth Milestones

Corporate ESG Performance

Sustainability & Responsible Growth

Sustainability is deeply embedded in our operations, We actively reduce our environmental footprint through

Renewable Energy

Carbon-Neutral

Utilization of Bio-Briquettes to minimize carbon emissions

Zero-Liquid-Discharge

Advanced ZLD systems ensuring zero environmental runoff

Water Reuse

100% water recovery and reuse across all specialized facilities

Executive Leadership

Mr. Anil Satwani

Founder, Chairman & Managing Director

With over 30 years of visionary leadership, Mr. Satwani has steered Symbiotec from a grassroots startup into a global titan in steroidal hormone manufacturing. His philosophy bridges high-end chemical synthesis with world-class operational standards

MEET THE BOARD

2,000+ Professionals

CRISIL A+ Credit Rating

40+ Countries